Saliva Test Identifies Hypogonadism in ESRD Patients
Salivary testosterone (Sal-T) can be used to diagnose androgen deficiency reliably in men with end-stage renal disease (ESRD), according to a Brazilian study.
Salivary testosterone (Sal-T) can be used to diagnose androgen deficiency reliably in men with end-stage renal disease (ESRD), according to a Brazilian study.
Patients referred to a nephrologist a year or more before they start dialysis have better odds of survival during the first year of treatment compared with patients who are referred later, even if they have diabetes mellitus or are aged 70 years or older, a study found.
Robot-assisted partial nephrectomy (RAPN) is a safe and feasible option for managing renal cell carcinoma (RCC) in obese patients, according to data from a recent study.
Long-term medication adherence after myocardial infarction (MI) in the elderly is low, especially in patients with kidney dysfunction, according to a study published online in the Clinical Journal of the American Society of Nephrology.
Medication adherence is low among patients with reduced renal function who have suffered a myocardial infarction (MI), according to a study published in the Clinical Journal of the American Society of Nephrology (2011; online ahead of print).
Finger length may be associated with prostate cancer risk, according to a study published in the British Journal of Cancer (2010; online ahead of print).
Prescribed dietary phosphate restriction, as practiced today, is not associated with improved survival among hemodialysis (HD) patients, according to a new study. In fact, it may even increase the risk of death.
Moderate and heavy alcohol consumption may be associated with an increased risk of declining visual acuity, but not diabetic retinopathy, in patients with type 2 diabetes, data suggest.
A new study provides more evidence that silodosin is an effective treatment for the relief of lower urinary tract symptoms (LUTS) in men with suspected benign prostatic hyperplasia (BPH).
Patients who undergo nephrectomy for renal tumors are at increased risk for adverse renal outcomes, a recent study found.